Jing Wang is an accomplished Principal Scientist at Genentech since April 2021, specializing in in vitro regulatory DMPK. Previously, Jing held the position of Senior Scientist at Denali Therapeutics, focusing on discovery and development DMPK from February 2019 to April 2021. Jing's career at Genentech began as a Senior Scientific Researcher from March 2015 to February 2019, and encompasses experience in DMPK roles at Threshold Pharmaceuticals and as an Applications Scientist at Labcyte. Early career highlights include roles at Optivia Biotechnology and Exelixis, where Jing worked as a Research Scientist, as well as contributions in enzymology at Axys/Celera Pharmaceuticals. Jing Wang's educational background includes degrees from the University of Washington and the University of Louisville School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices